Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   MYLAN
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
MYLAN
Dec-18
AJANTA PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,4263,967-   
Low Rs1,0622,184-   
Sales per share (Unadj.) Rs297.21,825.4-  
Earnings per share (Unadj.) Rs46.749.6-  
Cash flow per share (Unadj.) Rs57.1391.3-  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.11,974.7-  
Shares outstanding (eoy) m125.91514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.21.7 248.4%   
Avg P/E ratio x26.662.0 42.9%  
P/CF ratio (eoy) x21.87.9 277.3%  
Price / Book Value ratio x4.61.6 296.9%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,6381,582,214 9.9%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m7,8510-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m37,426939,158 4.0%  
Other income Rs m9860-   
Total revenues Rs m38,413939,158 4.1%   
Gross profit Rs m7,833243,019 3.2%  
Depreciation Rs m1,308175,847 0.7%   
Interest Rs m5845,170 0.1%   
Profit before tax Rs m7,45322,002 33.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,573-3,500 -44.9%   
Profit after tax Rs m5,88025,502 23.1%  
Gross profit margin %20.925.9 80.9%  
Effective tax rate %21.1-15.9 -132.6%   
Net profit margin %15.72.7 578.6%  
BALANCE SHEET DATA
Current assets Rs m28,252524,425 5.4%   
Current liabilities Rs m11,393382,364 3.0%   
Net working cap to sales %45.015.1 297.8%  
Current ratio x2.51.4 180.8%  
Inventory Days Days6684 78.8%  
Debtors Days Days1093 11.0%  
Net fixed assets Rs m18,707182,181 10.3%   
Share capital Rs m253500 50.5%   
"Free" reserves Rs m33,6240-   
Net worth Rs m33,8771,015,998 3.3%   
Long term debt Rs m131,096,588 0.0%   
Total assets Rs m47,0472,725,301 1.7%  
Interest coverage x128.61.5 8,648.6%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.80.3 230.8%   
Return on assets %12.62.6 486.7%  
Return on equity %17.42.5 691.5%  
Return on capital %22.23.2 697.0%  
Exports to sales %59.90-   
Imports to sales %11.50-   
Net fx Rs m18,1270-   
CASH FLOW
From Operations Rs m7,918195,157 4.1%  
From Investments Rs m-5,596-100,875 5.5%  
From Financial Activity Rs m-1,079-90,916 1.2%  
Net Cashflow Rs m1,2431,617 76.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare AJANTA PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare AJANTA PHARMA With: GODAVARI DRU  BIOCON   WYETH  CORAL LAB.  VAISHALI PHARMA   



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.